Clinical characteristics of patients with myositis and autoantibodies to different fragments of the Mi-2 beta antigen
about
Heterogeneity of autoantibodies in 100 patients with autoimmune myositis: insights into clinical features and outcomes.Complement membrane attack complex is related with immune-mediated necrotizing myopathy.Dermatomyositis associated with hepatitis B virus-related hepatocellular carcinomaMyositis-specific autoantibodies: detection and clinical associations.The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositisClinical Manifestations and Myositis-Specific Autoantibodies Associated with Physical Dysfunction after Treatment in Polymyositis and Dermatomyositis: An Observational Study of Physical Dysfunction with Myositis in JapanDevelopments in the scientific and clinical understanding of inflammatory myopathies.Predictors of clinical improvement in rituximab-treated refractory adult and juvenile dermatomyositis and adult polymyositis.Cutting edge issues in polymyositis.Autoimmune myopathies: autoantibodies, phenotypes and pathogenesis.Review: immune-mediated necrotizing myopathies--a heterogeneous group of diseases with specific myopathological features.Pathomechanisms of inflammatory myopathies: recent advances and implications for diagnosis and therapies.Autoantibodies in polymyositis and dermatomyositis.A new ELISA for dermatomyositis autoantibodies: rapid introduction of autoantigen cDNA to recombinant assays for autoantibody measurement.Myositis-specific autoantibodies: an important tool to support diagnosis of myositis.Integrated classification of inflammatory myopathies.Expression of the dermatomyositis autoantigen Mi-2 in regenerating muscle.Polymyositis and dermatomyositis: Disease spectrum and classification.Identification of multiple cancer-associated myositis-specific autoantibodies in idiopathic inflammatory myopathies: a large longitudinal cohort study.Idiopathic inflammatory myopathies overlapping with systemic diseases.Diagnostic performance and validation of autoantibody testing in myositis by a commercial line blot assay.A New Immunodot Assay for Multiplex Detection of Autoantibodies in a Cohort of Italian Patients With Idiopathic Inflammatory Myopathies.
P2860
Q33293736-E1ED1B02-B78D-4380-BBF7-0C35E5D3BEE0Q34029161-0A572666-47CD-4662-BFA4-9759E71E14F8Q34660484-A1BB592D-4BAA-4D59-91B4-1C9916F48312Q35309808-0D6AC0D5-4615-49CF-8DD4-8C71DC29B919Q36013885-31C99710-B411-44E1-81FA-91EB1061C91AQ36559044-6706D6BA-029F-40C3-8CD4-105F284AAC93Q37306840-8E8965B5-D199-4D7F-A95D-ECDCA90B59ADQ37704799-3118B83D-F7F6-490B-91FD-01E35DD66B87Q37824617-97920294-294D-43B2-8ACD-B6A64E81E56EQ37886653-340D10E9-9EB9-4C89-8027-6127F237983EQ38044467-FA0F8E72-623D-4A6B-8939-3F67D529C0CAQ38089081-E88A44D3-15F5-4FA7-B928-4BB9ED4CCD55Q38099556-59191B74-D94A-42C5-99E1-96886778934DQ38177793-689480D9-45BE-455F-A9D5-0EE60C28593FQ38646384-C545D793-27AB-45F7-8D90-BAC03D2FCBA8Q39027323-4A20D4BA-3F67-4947-905D-865319B59AE4Q39288750-D16FD571-B454-4A88-9770-E561A5A03685Q41674222-D95D3C2C-F406-4FE5-91CE-6408734C3334Q47165421-E4B2EDE4-156F-4E9F-9647-E8D673F852C6Q47401892-155E8325-9949-4C82-87E8-494806A4C698Q51668925-6A261161-A26E-442A-8967-5BA90C01EA46Q53790402-6AE48105-F0DA-4042-9C0B-2B9801C10C3C
P2860
Clinical characteristics of patients with myositis and autoantibodies to different fragments of the Mi-2 beta antigen
description
2006 nî lūn-bûn
@nan
2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Clinical characteristics of pa ...... ments of the Mi-2 beta antigen
@ast
Clinical characteristics of pa ...... ments of the Mi-2 beta antigen
@en
Clinical characteristics of pa ...... ments of the Mi-2 beta antigen
@nl
type
label
Clinical characteristics of pa ...... ments of the Mi-2 beta antigen
@ast
Clinical characteristics of pa ...... ments of the Mi-2 beta antigen
@en
Clinical characteristics of pa ...... ments of the Mi-2 beta antigen
@nl
prefLabel
Clinical characteristics of pa ...... ments of the Mi-2 beta antigen
@ast
Clinical characteristics of pa ...... ments of the Mi-2 beta antigen
@en
Clinical characteristics of pa ...... ments of the Mi-2 beta antigen
@nl
P2093
P2860
P356
P1476
Clinical characteristics of pa ...... ments of the Mi-2 beta antigen
@en
P2093
Hengstman GJ
Moutsopoulos HM
Vencovsky J
Vree Egberts WT
van Engelen BG
van Venrooij WJ
P2860
P304
P356
10.1136/ARD.2005.040717
P407
P577
2006-02-01T00:00:00Z